Please login to the form below

Not currently logged in
Email:
Password:

Ovarian canncer

This page shows the latest Ovarian canncer news and features for those working in and with pharma, biotech and healthcare.

Another NICE no for AZ’s new ovarian cancer drug

Another NICE no for AZ’s new ovarian cancer drug

Cost watchdog wants more information for Lynparza.  . NICE is once again saying no to AstraZeneca's new ovarian cancer drug - but is opening up a second consultation on its decision. ... The Institute is minded, in preliminary draft guidance, to reject

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...